|
End-of-day quote
Shanghai S.E.
2026-09-14
|
5-day change | 1st Jan Change | ||
| 37.61 CNY | +0.80% |
|
-1.18% | -11.61% |
| Market Cap | 11.97B 1.79B 1.54B 1.46B 1.32B 2.48B 171B 2.5B 17.39B 6.7B 86.75B 6.71B 6.56B 276B | P/E 2024 |
11.3x | P/E 2025 | 14.6x |
|---|---|---|---|---|---|
| Enterprise Value | 9.36B 1.4B 1.21B 1.14B 1.03B 1.94B 134B 1.96B 13.6B 5.24B 67.85B 5.25B 5.13B 216B | EV / Sales 2024 |
3.4x | EV / Sales 2025 | 3.72x |
| Free-Float |
39.36% | Yield 2024 |
5.3% | Yield 2025 | 4.13% |
| 1 day | +0.80% | ||
| 1 week | -1.18% | ||
| Current month | -2.03% | ||
| 1 month | -6.09% | ||
| 3 months | +2.79% | ||
| 6 months | -14.15% | ||
| Current year | -11.61% |
| 1 week | 36.72 |  | 38.43 |
| 1 month | 36.72 | | 41.86 |
| Current year | 34.8 | | 46 |
| 1 year | 34.8 | | 57.2 |
| 3 years | 26.95 | | 57.98 |
| 5 years | 22.73 | | 57.98 |
| 10 years | 13.54 | | 140.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yuan Dong Guo
CEO | Chief Executive Officer | 56 | 2014-11-19 |
Jun Chen
DFI | Director of Finance/CFO | 48 | 2019-10-24 |
Li Li Wen
IRC | Investor Relations Contact | 46 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Da Bin Chen
CHM | Chairman | 70 | 2015-01-07 |
Yu Cheng Zhou
BRD | Director/Board Member | 44 | 2015-01-07 |
Yuan Dong Guo
BRD | Director/Board Member | 56 | 2015-01-07 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.80% | -1.18% | -33.35% | -1.37% | 1.77B | |
| +2.02% | -0.96% | +50.69% | +90.07% | 994B | |
| +0.28% | -3.24% | +49.57% | +62.40% | 640B | |
| +1.81% | +2.07% | +19.89% | +73.17% | 454B | |
| +5.00% | +1.23% | +36.64% | +40.84% | 337B | |
| +1.68% | -12.09% | +15.25% | +26.83% | 261B | |
| +3.81% | +1.23% | +3.05% | +14.86% | 246B | |
| +1.10% | -12.75% | +38.03% | +48.31% | 204B | |
| +1.43% | -6.19% | -19.49% | -58.38% | 190B | |
| +1.87% | -3.04% | +27.81% | +89.38% | 178B | |
| Average | +1.48% | -5.37% | +18.81% | +38.61% | 350.65B | |
| Weighted average by Cap. | +1.04% | -4.41% | +33.43% | +57.57% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.81B 419M 362M 342M 310M 581M 40.03B 587M 4.08B 1.57B 20.34B 1.57B 1.54B 64.63B | 2.98B 445M 385M 363M 329M 617M 42.53B 623M 4.33B 1.67B 21.6B 1.67B 1.63B 68.66B |
| Net income | 1.05B 157M 136M 128M 116M 218M 15B 220M 1.53B 588M 7.62B 589M 576M 24.21B | 938M 140M 121M 114M 103M 194M 13.38B 196M 1.36B 525M 6.8B 526M 514M 21.6B |
| Net Debt | -2.35B -351M -303M -286M -259M -487M -33.54B -492M -3.42B -1.32B -17.04B -1.32B -1.29B -54.15B | -2.61B -389M -337M -318M -288M -540M -37.21B -546M -3.79B -1.46B -18.9B -1.46B -1.43B -60.07B |
Employees
671
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-14 | CN¥37.61 | +0.80% | 2,484,160 |
| 26-09-11 | CN¥37.31 | -1.61% | 3,709,510 |
| 26-09-10 | CN¥37.92 | -0.34% | 1,627,970 |
| 26-09-09 | CN¥38.05 | -0.70% | 2,100,878 |
| 26-09-08 | CN¥38.32 | +0.34% | 2,214,111 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600211 Stock
Select your edition
All financial news and data tailored to specific country editions
